ARRY
Price
$4.93
Change
+$0.07 (+1.44%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
2.22B
40 days until earnings call
SGMO
Price
$0.65
Change
+$0.08 (+14.04%)
Updated
Apr 2 closing price
Capitalization
146.78M
27 days until earnings call
Ad is loading...

ARRY vs SGMO

Header iconARRY vs SGMO Comparison
Open Charts ARRY vs SGMOBanner chart's image
Array Technologies
Price$4.93
Change+$0.07 (+1.44%)
Volume$100.4K
Capitalization2.22B
Sangamo Therapeutics
Price$0.65
Change+$0.08 (+14.04%)
Volume$17.73M
Capitalization146.78M
ARRY vs SGMO Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. SGMO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongBuy and SGMO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (SGMO: $0.65)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGMO’s FA Score shows that 0 FA rating(s) are green while.

  • SGMO’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 6 bearish.
  • SGMO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGMO is a better buy in the short-term than ARRY.

Price Growth

SGMO (@Biotechnology) experienced а -22.70% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

SGMO is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than SGMO($147M). ARRY YTD gains are higher at: -18.212 vs. SGMO (-35.961). ARRY has higher annual earnings (EBITDA): 276M vs. SGMO (-123.99M). ARRY has more cash in the bank: 249M vs. SGMO (39.2M). SGMO has less debt than ARRY: SGMO (27.7M) vs ARRY (730M). ARRY has higher revenues than SGMO: ARRY (1.58B) vs SGMO (52.3M).
ARRYSGMOARRY / SGMO
Capitalization2.22B147M1,512%
EBITDA276M-123.99M-223%
Gain YTD-18.212-35.96151%
P/E Ratio26.23N/A-
Revenue1.58B52.3M3,015%
Total Cash249M39.2M635%
Total Debt730M27.7M2,635%
FUNDAMENTALS RATINGS
ARRY vs SGMO: Fundamental Ratings
ARRY
SGMO
OUTLOOK RATING
1..100
7118
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8590
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGMO's Valuation (61) in the Biotechnology industry is somewhat better than the same rating for ARRY (98). This means that SGMO’s stock grew somewhat faster than ARRY’s over the last 12 months.

SGMO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that SGMO’s stock grew similarly to ARRY’s over the last 12 months.

SGMO's SMR Rating (99) in the Biotechnology industry is in the same range as ARRY (100). This means that SGMO’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (85) in the Biotechnology industry is in the same range as SGMO (90). This means that ARRY’s stock grew similarly to SGMO’s over the last 12 months.

ARRY's P/E Growth Rating (25) in the Biotechnology industry is significantly better than the same rating for SGMO (100). This means that ARRY’s stock grew significantly faster than SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYSGMO
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPECX25.24N/A
N/A
Alger Spectra A
PYVLX15.94N/A
N/A
Payden Equity Income
VBAIX46.83N/A
N/A
Vanguard Balanced Index I
AFGGX16.80N/A
N/A
Yorktown Growth A
EKSDX5.88N/A
N/A
Allspring Diversified Income Bldr Adm

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+14.58%
AXON - SGMO
51%
Loosely correlated
+3.18%
ARRY - SGMO
48%
Loosely correlated
+1.65%
BCRX - SGMO
46%
Loosely correlated
+2.48%
RPRX - SGMO
45%
Loosely correlated
+0.35%
AGEN - SGMO
43%
Loosely correlated
+1.87%
More